Selective binding of bladder muscarinic receptors in relation to the pharmacokinetics of a novel antimuscarinic agent, imidafenacin, to treat overactive bladder
S Yamada, M Seki, M Ogoda, A Fukata… - … of Pharmacology and …, 2011 - ASPET
The binding of orally administered imidafenacin, used to treat overactive bladders, to muscarinic
receptors in rat tissue was characterized based on pharmacokinetics. The binding in six …
receptors in rat tissue was characterized based on pharmacokinetics. The binding in six …
Comparative characterization of lung muscarinic receptor binding after intratracheal administration of tiotropium, ipratropium, and glycopyrrolate
M Ogoda, R Niiya, T Koshika, S Yamada - Journal of pharmacological …, 2011 - Elsevier
The aim of the current study was to characterize comparatively the binding of muscarinic
receptor in the lung of rats intratracheally administered anticholinergic agents (tiotropium, …
receptor in the lung of rats intratracheally administered anticholinergic agents (tiotropium, …
[HTML][HTML] Characterization of muscarinic and P2X receptors in the urothelium and detrusor muscle of the rat bladder
M Ogoda, Y Ito, Y Fuchihata, S Onoue… - Journal of …, 2016 - Elsevier
Muscarinic and purinergic (P2X) receptors play critical roles in bladder urothelium under
physiological and pathological conditions. Aim of present study was to characterize these …
physiological and pathological conditions. Aim of present study was to characterize these …
Muscarinic receptor binding of imidafenacin in the human bladder mucosa and detrusor and parotid gland
M Seki, M Ogoda, S Kuraoka, A Otsuka… - LUTS: Lower Urinary …, 2011 - Wiley Online Library
Objectives: The current study aimed to characterize comparatively the binding of imidafenacin
to muscarinic receptors in the human bladder mucosa and detrusor muscle and parotid …
to muscarinic receptors in the human bladder mucosa and detrusor muscle and parotid …
Angioscopic evaluation of atrial septal defect closure device neo‐Endothelialization
…, M Izumo, H Kawaguchi, S Ogoda… - Journal of the …, 2021 - Am Heart Assoc
Background Current guidelines recommend at least 6 months of antithrombotic therapy and
antibiotic prophylaxis after septal‐occluding device deployment in transcatheter closure of …
antibiotic prophylaxis after septal‐occluding device deployment in transcatheter closure of …
Puerariae flos alleviates metabolic diseases in Western diet-loaded, spontaneously obese type 2 diabetic model mice
K Kubo, T Shimada, R Onishi, M Tsubata… - Journal of natural …, 2012 - Springer
Puerariae flos extract (PFE) has been reported to have many effects, including preventing
the development of hangovers, liver protective effects, and an estrogenic effect. In addition, …
the development of hangovers, liver protective effects, and an estrogenic effect. In addition, …
[HTML][HTML] Endothelin-1 receptors in rat tissues: characterization by bosentan, ambrisentan and CI-1020
Y Yokoyama, A Osano, H Hayashi, K Itoh… - Biological and …, 2014 - jstage.jst.go.jp
The present study aimed to characterize comparatively endothelin-1 (ET-1) receptors in rat
tissues by radioligand binding assay using [125 I] ET-1 and to examine receptor binding after …
tissues by radioligand binding assay using [125 I] ET-1 and to examine receptor binding after …
Neoadjuvant intra-arterial doxorubicin chemotherapy in combination with low dose radiotherapy for the treatment of locally advanced transitional cell carcinoma of the …
Y Sumiyoshi, K Yokota, M Akiyama, Y Inoue… - The Journal of …, 1994 - Elsevier
Between 1979 and 1990, 60 patients with locally advanced bladder cancer (stages T2 to
4NXM0) were treated with intra-arterial doxorubicin chemotherapy in combination with low …
4NXM0) were treated with intra-arterial doxorubicin chemotherapy in combination with low …
[CITATION][C] Bladder Selectivity of Imidafenacin, a Novel Antimuscarinic Agent Developed to Treat Overactive Bladder
S Yamada, A Yoshida, M Ogoda, Y Fuchihata…
[CITATION][C] Muscarinic receptor binding characteristics in lung and other tissues after intratracheal administration of anticholinergic agents to treat chronic obstructive …
M Ogoda, R Niiya, Y Ito… - JOURNAL OF …, 2010 - … SOC EDITORIAL OFF, KANTOHYA …